Want to join the conversation?
$AMGN's pivotal Phase 3 head-to-head ENDEAVOR study results published in The Lancet Oncology demonstrate superiority of Kyprolis (carfilzomib) combination over Velcade (bortezomib) in patients with relapsed multiple myeloma, which is a cancer that forms in a type of white blood cell called a plasma cell.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!